Drug Substance Portfolio
Siegfried offers a portfolio of controlled substances and other Active Pharmaceutical Ingredients (APIs) that is focused on moderate to severe pain management and dependency treatment. As a leading global supplier, Siegfried’s range of products includes opiates, methylphenidates, barbiturates, and nicotine products. Specifically, Siegfried offers Naltrexone, Naloxone and Buprenorphine, and we continue to add new API’s to our portfolio.
Our controlled substance portfolio offers a distinct advantage - we can consolidate our sourcing activities for Europe and the US through one global procurement organization. Efforts are continuously made to ensure security of supply. Critical raw materials are obtained through key partnerships, and safety stock is a priority when anticipating demand fluctuations.
As a well experienced and recognized expert in controlled substances, Siegfried holds the necessary regulatory licenses to import and export key raw materials for manufacturing large volumes of controlled substances >100 tons annually. With agent representatives in approximately 20 countries, Siegfried maintains a strong track record in the supply and export of APIs to the U.S., Europe, and the rest of the world.
Siegfried has an outstanding global compliance record and we take pride in providing superior regulatory and technical support for our customers. You can expect more quality, reliability and security of supply with Siegfried than you will find elsewhere in the industry.
For additional information regarding Siegfried’s entire product line, please consult the product lists:
> product list
> product list USA